RotationRx · Drugs · Scores · Protocols · Diagnoses · Specialties

← Drug Reference

Bumetanide

edema associated with congestive heart failure, hepatic disease, renal disease

Boxed warning

  • WARNING Bumetanide is a potent diuretic which, if given in excessive amounts, can lead to a profound diuresis with water and electrolyte depletion. Therefore, careful medical supervision is required, and dose and dosage schedule have to be adjusted to the individual patient’s needs ( see DOSAGE AND ADMINIST RAT ION ).

Indications

  • edema associated with congestive heart failure
  • hepatic disease
  • renal disease

Adult dosing

  • initial oral: dose: 0.5; unit: mg; route: PO; interval: 0.5 mg to 2 mg once daily; fixed: true; labelExcerpt: The usual total daily dosage of bumetanide tablets are 0.5 mg to 2 mg and in most patients are given as a single dose. If the diuretic response to an initial dose of bumetanide tablets is not adequate, in view of its rapid onset and short duration of action, a second or third dose may be given at 4- to 5- hour intervals up to a maximum daily dose of 10 mg.

Pediatric dosing

  • Consult pharmacy/current label

Renal adjustment

  • Consult pharmacy/current label

Hepatic adjustment

  • Keep dosage to a minimum.

Contraindications

  • Anuria
  • Hepatic coma
  • Severe electrolyte depletion
  • Hypersensitivity to bumetanide

Clinical pearls

  • Potent diuretic; monitor for volume and electrolyte depletion.
  • Patients allergic to sulfonamides may have cross-hypersensitivity.
  • Potentially ototoxic; risk increases with rapid IV administration at high doses.
  • Intermittent dosing (e.g., alternate days) is recommended for continued control of edema.

Source and review

  • DailyMed label (bumetanide), Set ID 43844210-3850-4431-848d-bd168cb3f21e, effective 2026-10-09. Last reviewed: 2026-11-11